KIORA PHARMACEUTICALS, INC.
Income Statement
| Line Item | FY2016 | FY2015 |
|---|---|---|
| Revenue | $669.3K | $0 |
| Cost of Revenue | — | — |
| Gross Profit | — | — |
| Gross Margin | — | — |
| Operating Expenses | ||
| Research & Development | $8.4M | $2.7M |
| SG&A Expense | $5.6M | $4.0M |
| Operating Income | $-13.3M | $-6.5M |
| Operating Margin | -1,993.7% | — |
| Interest Expense | $275 | $1.9M |
| Pretax Income | $-13.3M | $-8.4M |
| Income Tax Expense | $0 | — |
| Net Income | $-13.3M | $-8.4M |
| Net Margin | -1,993.8% | — |
| EPS (Basic) | $-0.06 | $-0.11 |
| EPS (Diluted) | $-0.06 | $-0.11 |
| Shares Outstanding (Basic) | 243.1M | 183.8M |
| Shares Outstanding (Diluted) | 243.1M | 183.8M |
| Dividends Per Share | — | — |